Immunogenicity and pathogenicity of temperature-sensitive modified respiratory syncytial virus in adult volunteers.
Single temperature-sensitive (ts) mutants of a subgroup A strain of respiratory syncytial (RS) virus whose multiplication is restricted at 39 degrees C in MRC-6 cells and double ts mutants that are restricted at 38 degrees C, were obtained following mutagenesis using 5-fluorouracil and acridine-like compounds. Isolation and propagation of the parental RSS-2 strain of RS virus and its derived ts mutants were carried out entirely in MRC-5 human diploid cells. The immunogenicity and disease-producing ability of four of these mutants and the parental unmodified strain have been assessed by intranasal administration into groups of about 20 adult volunteers. The results of these trials indicate that the capacity of the parental RSS-2 strain to produce upper respiratory tract infection in adults was not diminished by limited propagation in MRC-5 cells. The mutants on the other hand were impaired in this respect to varying extents. The double mutant tslB in particular has characteristics that suggest that it may be suitable for further development as a live RS virus vaccine. It retained near normal immunogenicity and replicative ability in the upper respiratory tract, while exhibiting greatly reduced disease-producing potential.
McKay
E
E
MRC Virology Unit, Institute of Virology, Glasgow, Scotland.
Higgins
P
P
Tyrrell
D
D
Pringle
C
C
D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis; D006801:Humans; D009154:Mutation; D012136:Respiratory Syncytial Viruses / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D012141:Respiratory Tract Infections / Q000209:etiology / Q000517:prevention & control; D010253:Respirovirus Infections / Q000209:etiology / Q000517:prevention & control; D013696:Temperature; D014765:Viral Vaccines / Q000302:isolation & purification
D000914:Antibodies, Viral; D014765:Viral Vaccines